Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 24 September 2016

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Predicting in-hospital mortality in cirrhosis with systemic inflammatory response syndrome

Low eosinophil count predicts in-hospital mortality in cirrhosis with systemic inflammatory response syndrome, reports June's issue of the European Journal of Gastroenterology & Hepatology.

News image

Absolute eosinophil count and procalcitonin level may have a prognostic value in critically ill patients.

However, their role in cirrhotic patients has never been studied.

Dr Hardik Kotecha and colleagues evaluated the role of absolute eosinophil count and procalcitonin, obtained at admission, in predicting in-hospital mortality in cirrhotic patients with systemic inflammatory response syndrome.

The research team estimated levels of absolute eosinophil count and procalcitonin were estimated at admission in 100 patients.

Their outcome was correlated with these baseline parameters.

The doctors examined that etiology of cirrhosis was alcohol, cryptogenic, viral, and others.

Their median model for end-stage liver disease and Child–Turcotte–Pugh scores were 24 and 11, respectively.

The researchers noted that infection was present in 59 patients, and the rest of the 41 patients had systemic inflammatory response syndrome without infection.

63 patients recovered from systemic inflammatory response syndrome
European Journal of Gastroenterology & Hepatology

There was a significant difference between the median levels of absolute eosinophil count, and procalcitonin between patients who had infection, and those who did not have infection.

The doctors found that 63 patients recovered from systemic inflammatory response syndrome, and were discharged, 33 patients died, and 4 patients received orthotopic liver transplantation during the same admission.

Baseline absolute eosinophil count and procalcitonin levels were significantly different between patients who recovered and died.

On multivariate analysis, baseline absolute eosinophil count values could independently predict in-hospital mortality, in addition to model for end-stage liver disease and serum sodium.

The area under receiver operating characteristic curve of absolute eosinophil count for predicting mortality was 0.785, and the best cutoff of absolute eosinophil count, obtained by Youden’s index, was 104 cells/cumm, indicating that patients with baseline absolute eosinophil count values less than 104 cells/cumm had higher in-hospital mortality.

Dr Hardik's team commented, "In critically ill cirrhotic patients with systemic inflammatory response syndrome, a baseline absolute eosinophil count value of less than 104 cells/cumm accurately predicts in-hospital mortality."

"The prediction of mortality by Absolute eosinophil count is independent of the model for end-stage liver disease score and serum sodium."

Euro J of Gastroenterol & Hepatol 2013: 25(6): 676-682
13 June 2013

Go to top of page Email this page Email this page to a colleague

 23 September 2016 
Exercise for NAFLD
 23 September 2016 
BMI history and fatty liver
 23 September 2016 
Sleep quality in nonalcoholic cirrhotic patients
 22 September 2016 
Predicting small-bowel Crohn’s disease
 22 September 2016 
Technology vs intervention for weight loss
 22 September 2016 
Colectomy outcomes for ulcerative colitis
 21 September 2016 
Cardiopulmonary exercise testing in liver transplant candidates
 21 September 2016 
Employment status and IBD
 21 September 2016 
Patients vs providers on nutrition in IBD
 20 September 2016 
Improving healthcare systems for viral Hepatitis
 20 September 2016 
GI benefits of COX-2 selective inhibitors
 20 September 2016 
Predicting relapse in Crohn's
 19 September 2016 
Prevalence of esophageal cancer in Barrett's
 19 September 2016 
Fecal microbiota transplantation and CDI in IBD
 19 September 2016 
Antibiotic resistance in Helicobacter pylori
 16 September 2016 
Low-residue diet before colonoscopy and bowel cleansing
 16 September 2016 
Genome-wide association in gastric cancer
 16 September 2016 
H. pylori in children with asthma
 15 September 2016 
Improving survival in cholangitis-associated septic shock
 15 September 2016 
Colorectal cancer survival and hospital volumes
 15 September 2016 
Primary sclerosing cholangitis and IBD
 14 September 2016 
Intestinal malabsorption and olmesartan
 14 September 2016 
Infection reduction strategy after colorectal resection
 14 September 2016 
Predicting long-term infliximab use in Crohn's
 13 September 2016 
Predicting survival in refractory celiac disease
 13 September 2016 
Cancer risk stratification in Barrett’s
 13 September 2016 
Screening vs non-screening colonoscopy
 12 September 2016 
Screening in familial colorectal cancer
 12 September 2016 
Metformin improves survival in pancreatic ductal cancer
 12 September 2016 
Consent guidelines for GI endoscopy procedures
 09 September 2016 
Development of IBS
 09 September 2016 
Safe and effective treatment for NASH
 09 September 2016 
Scale for stool measurement in diarrhea-IBS
 08 September 2016 
Prognostic factors for infliximab in Crohn's
 08 September 2016 
Chronic Hep B vs chronic Hep C and mortality
 08 September 2016 
Hematological malignancies in IBD
 07 September 2016 
IBD relapse during pregnancy
 07 September 2016 
New treatments for ulcerative colitis
 07 September 2016 
Alternative to nucleic acid testing in HCV
 06 September 2016 
Endoscopy clinic no-shows
 06 September 2016 
Risk of infection after elective colorectal surgery
 06 September 2016 
EHealth technologies in IBD
 05 September 2016 
Esophageal impedance monitoring
 05 September 2016 
Family history and IBD clinical course
 05 September 2016 
Biomarker for IBD and GI cancer
 02 September 2016 
Dietary carbohydrate intake, insulin resistance and GERD 
 02 September 2016 
Postpolypectomy bleeding in the colorectum
 02 September 2016 
Postop recurrence of Crohn's
 01 September 2016 
Prognostic test for liver transplants
 01 September 2016 
Recovery after colorectal surgery in elderly patients
 01 September 2016 
Obesity and post-ERCP pancreatitis
 30 August 2016 
NAFLD and carotid atherosclerosis
 30 August 2016 
Quality improvement program after colorectal surgery
 30 August 2016 
Gut microbial diversity in smokers with Crohn's
 29 August 2016 
Reducing Hep B-related HCC
 29 August 2016 
Hep B immunization of infants for liver cancer
 29 August 2016 
Risk factor for post-ERCP pancreatitis
 26 August 2016 
Reasons for premature surveillance colonoscopy
 26 August 2016 
Celiac disease therapeutics
 26 August 2016 
Bleeding after endoscopic dissection-induced gastric ulcers

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2016 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us